State Ledger
Company profile

MetaVia Inc. CIK 1638287

Ticker
MTVA (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Cambridge, MA 02138
Fiscal year end
2025 (FY)
Market Data
Close
$1.43
Change
-$0.01
Change %
-0.69%
Volume
476

MTVA · trading date Oct 13, 2026 · previous close $1.44 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$12.97M
Total assets
$11.12M
Total liabilities
$5.79M
Stockholders' equity
$5.33M
Cash & equivalents
$10.28M
Operating income
-$13.71M
Operating cash flow
-$15.70M
Capital expenditures
$2.0K

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$15.70M
Free cash flow margin
—
Liabilities / assets
52.1%
Equity / assets
47.9%
CapEx / revenue
—
Operating cash flow / net income
1.21×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$12.97M $11.12M $5.79M $5.33M
2024 — -$27.59M $16.26M $8.33M $7.93M
2023 — -$12.47M $22.78M $6.10M $16.69M
2022 — -$13.97M $33.53M $11.78M $21.75M
2021 — -$15.28M $16.80M $2.20M $14.60M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-09
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02138
545 CONCORD AVENUE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies